Show simple item record

dc.contributor.authorLin, S
dc.contributor.authorShah, A
dc.contributor.authorHernández-Gil, J
dc.contributor.authorStanziola, A
dc.contributor.authorHarriss, BI
dc.contributor.authorMatsunaga, TO
dc.contributor.authorLong, N
dc.contributor.authorBamber, J
dc.contributor.authorTang, M-X
dc.date.accessioned2017-07-19T15:02:54Z
dc.date.issued2017-06-01
dc.identifier.citationPhotoacoustics, 2017, 6 pp. 26 - 36
dc.identifier.issn2213-5979
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/718
dc.identifier.eissn2213-5979
dc.identifier.doi10.1016/j.pacs.2017.04.001
dc.description.abstractWe demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast enhancement: 1) photoacoustic imaging contrast, 2) ultrasound contrast with optical activation, and 3) ultrasound contrast with acoustic activation. This agent, which we name 'Cy-droplet', has the following novel features. It comprises a highly volatile perfluorocarbon for easy versatile activation, and a near-infrared optically absorbing dye chosen to absorb light at a wavelength with good tissue penetration. It is manufactured via a 'microbubble condensation' method. The phase-transition of Cy-droplets can be optically triggered by pulsed-laser illumination, inducing photoacoustic signal and forming stable gas bubbles that are visible with echo-ultrasound in situ. Alternatively, Cy-droplets can be converted to microbubble contrast agents upon acoustic activation with clinical ultrasound. Potentially all modes offer extravascular contrast enhancement because of the sub-micron initial size. Such versatility of acoustic and optical 'triggerability' can potentially improve multi-modality imaging, molecularly targeted imaging and controlled drug release.
dc.formatElectronic-eCollection
dc.format.extent26 - 36
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER GMBH
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleOptically and acoustically triggerable sub-micron phase-change contrast agents for enhanced photoacoustic and ultrasound imaging.
dc.typeJournal Article
dcterms.dateAccepted2017-04-08
rioxxterms.versionofrecord10.1016/j.pacs.2017.04.001
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfPhotoacoustics
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Ultrasound & Optical Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Ultrasound & Optical Imaging
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume6
pubs.embargo.termsNot known
icr.researchteamUltrasound & Optical Imaging
dc.contributor.icrauthorShah, Anant
dc.contributor.icrauthorBamber, Jeffrey


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0